4//SEC Filing
Holveck David 4
Accession 0001209191-10-011543
CIK 0001100962other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:14 PM ET
Size
15.8 KB
Accession
0001209191-10-011543
Insider Transaction Report
Form 4
Holveck David
DirectorPresident & CEO
Transactions
- Award
2007 Stock Incentive Plan Stock Options
2010-02-19+168,733→ 168,733 totalExercise: $20.61Exp: 2020-02-19→ Common Stock (168,733 underlying) - Award
2007 Stock Incentive Plan Restricted Stock Units (RSU)
2010-02-19+59,437→ 59,437 totalExercise: $0.00Exp: 2014-02-19→ Common Stock (59,437 underlying) - Award
2007 Stock Incentive Plan Performance Shares
2010-02-19+59,437→ 59,437 totalExercise: $0.00→ Common Stock (59,437 underlying)
Footnotes (6)
- [F1]Upon each vesting date, each vested restricted stock unit automatically converts into one (1) share of Endo Pharmaceuticals Holdiings Inc. common stock.
- [F2]These restricted stock units (RSUs) generally vest 100% on the fourth anniversary of the date of grant: February 19, 2014. Upon vesting, we consider the underlying RSUs to be expired.
- [F3]These securities were granted to Mr. Holveck in consideration of his services as the President & Chief Executive Officer of Endo Pharmaceuticals Holdings Inc.
- [F4]Representing the right to buy shares of common stock, par value $0.01 per share, of Endo Pharmaceuticals Holdings Inc.
- [F5]These stock options are generally exercisable 25% per year on each of February 19, 2011, February 19, 2012, February 19, 2013 and February 19, 2014.
- [F6]Represents target quantity of shares issuable. The exact number of shares issuable will be determined on achievement of certain company performance targets over a cumulative 3-year period, as determined by the Compensation Committee of the Board of Directors of Endo Pharmaceuticals Holdings Inc. The executive can earn between 0% and 200% of the target shares.
Issuer
ENDO PHARMACEUTICALS HOLDINGS INC
CIK 0001100962
Entity typeother
Related Parties
1- filerCIK 0001429993
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 7:14 PM ET
- Size
- 15.8 KB